View text source at Wikipedia
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Judith Klein-Seetharaman | |
---|---|
Born | May 30, 1972 |
Alma mater | University of Cologne Massachusetts Institute of Technology |
Scientific career | |
Institutions | Carnegie Mellon Colorado School of Mines Arizona State University University of Warwick University of Pittsburgh |
Thesis | Visual signal transduction : studies of light-induced conformational changes in the cytoplasmic face of rhodopsin. (2000) |
Judith Klein-Seetharaman (born May 30, 1971) is an American-German biochemist who is a professor at the Arizona State University. Her research considers the structure-function properties of proteins using computational bio-linguistics. She was supported by the Bill & Melinda Gates Foundation to identify novel therapies to tackle HIV.
Klein-Seetharaman was born in Germany. She completed her undergraduate training at the University of Cologne, where she earned dual honours in biology and chemistry.[1][2] After earning her doctorate, she moved to the United States, where she worked in the laboratory of Har Gobind Khorana at the Massachusetts Institute of Technology.[1][2] Her research considered conformational changes in rhodopsin, the G protein coupled receptor.[3] She was a postdoctoral researcher at MIT with Harald Schwalbe, focusing on nuclear magnetic resonance spectroscopy. After eight months as a postdoc, Klein-Seetharaman moved Carnegie Mellon University where she worked with Raj Reddy in biology. She was eventually appointed to the faculty at Carnegie Mellon.[1][4]
Klein-Seetharaman moved to the University of Pittsburgh as an assistant professor in 2002 and was promoted to associate professor in 2009.[1] She joined the Warwick Medical School as a professor in medicine in 2013.[1] She returned to the[United States in 2017, first as a professor at the Colorado School of Mines and then as a professor at the Arizona State University in 2021.[1] Her research looks to uncover the structure-property relationships of membrane proteins.[2]